Inventor · disambiguated record
Chris Rundfeldt
Also filed as: RUNDFELDT CHRIS
15 granted patents·27 pending applications·274 citations·filing 1996–2022
93Inventor score
Top patents by PatentIndex Score
42 records- 0186US7309713B2Use of the non-opiate analgesic drug flupirtine for the treatment of overactive bladder and associated diseases including urge incontinence, urinary flow problems as a result of prostate hyperplasia and irritable bowel syndromeELBION AG·Filed 2006·Granted Dec 18, 2007·25 cites·27 claims
- 0285US6117900AUse of retigabine for the treatment of neuropathic painASTA MEDICA AG·Filed 1999·Granted Sep 12, 2000·69 cites·8 claims
- 0383US8859540B2Use of dihydroimidazolones for the treatment of dogsRUNDFELDT CHRIS·Filed 2007·Granted Oct 14, 2014·8 cites·3 claims
- 0482US5852053AUse of 2-4-amino-4-(4-fluorobenzylamino) (-1-ethoxy-carbonylaminobenzene for the prophylaxis and treatment of the neurodegenerative disordersASTA MEDICA AG·Filed 1996·Granted Dec 22, 1998·51 cites·14 claims
- 0581US2022168255A1Pharmaceutical composition containing dimethyl fumarate for administration at a low daily doseBIOGEN SWISS MFG GMBH·Filed 2022·Application pending·0 cites
- 0679US5849789AUse of 4-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene for the prophylaxis and treatment of reduced cerebral blood supplyASTA MEDICA AG·Filed 1997·Granted Dec 15, 1998·41 cites·4 claims
- 0777US7550465B2Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing themELBION GMBH·Filed 2007·Granted Jun 23, 2009·6 cites·11 claims
- 0877US2019201369A1Pharmaceutical composition containing dimethyl fumarate for administration at a low daily doseFWP IP APS·Filed 2019·Application pending·0 cites
- 0976US8962617B2Use of dihydroimidazolones for the treatment of dogsRUNDFELDT CHRIS·Filed 2012·Granted Feb 24, 2015·3 cites·6 claims
- 1076US2019125711A1Pharmaceutical composition containing dimethyl fumarate for administration at a low daily doseFWP IP APS·Filed 2018·Application pending·0 cites
- 1175US7166637B2Hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing themELBION AG·Filed 2003·Granted Jan 23, 2007·12 cites·16 claims
- 1275US6472165B1Modulatory binding site in potassium channels for screening and finding new active ingredientsDRESDEN ARZNEIMITTEL·Filed 1999·Granted Oct 29, 2002·44 cites·11 claims
- 1375US2016206587A1Pharmaceutical composition containing dimethyl fumarate for administration at a low daily doseFORWARD PHARMA AS·Filed 2014·Application pending·0 cites
- 1475US2016206586A1Pharmaceutical composition containing dimethyl fumarate for administration at a low daily doseFORWARD PHARMA AS·Filed 2014·Application pending·0 cites
- 1575US2021290582A1Pharmaceutical composition containing dimethyl fumarate for administration at a low daily doseBIOGEN SWISS MFG GMBH·Filed 2020·Application pending·0 cites
- 1675US2018338946A1Pharmaceutical composition containing dimethyl fumarate for administration at a low daily doseFWP IP APS·Filed 2018·Application pending·0 cites
- 1774US2018256530A1Pharmaceutical composition containing dimethyl fumarate for administration at a low daily doseFWP IP APS·Filed 2018·Application pending·0 cites
- 1873US2018092875A1Pharmaceutical composition containing dimethyl fumarate for administration at a low daily doseFWP IP APS·Filed 2017·Application pending·0 cites
- 1972US2018021289A1Pharmaceutical composition containing dimethyl fumarate for administration at a low daily doseFWP IP APS·Filed 2017·Application pending·0 cites
- 2071US2017231943A1Pharmaceutical composition containing dimethyl fumarate for administration at a low daily doseFORWARD PHARMA AS·Filed 2017·Application pending·0 cites
- 2164US9469611B2Use of dihydroimidazolones for the treatment of dogsBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2014·Granted Oct 18, 2016·0 cites·20 claims
- 2262US7067536B24-,6- or 7-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agentsELBION AG·Filed 2004·Granted Jun 27, 2006·2 cites·7 claims
- 2361US7211583B27-azaindoles and the use thereof as therapeutic agentsELBION AG·Filed 2004·Granted May 1, 2007·2 cites·14 claims
- 2458US2009239874A1Pyrido[3,2-e]pyrazines, their use as inhibitors of phospohodiesterase 10, and processes for preparing themHOFGEN NORBERT·Filed 2009·Application pending·0 cites
- 2555US2016367562A1Use of dihydroimidazolones for the treatment of dogsBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2016·Application pending·0 cites
- 2654US2008114032A1Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptorLANGEN BARBARA·Filed 2007·Application pending·0 cites
- 2753US2005070537A1Use of dihydroimidazolones for the treatment of dogsFiled 2003·Application pending·0 cites
- 2851US2005032863A1Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptorFiled 2004·Application pending·0 cites
- 2949US2007093531A1Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing themELBION AG·Filed 2006·Application pending·0 cites
- 3049US2022193028A1Therapeutic combinations, liquid pharmaceutical compositions, kits for their preparation, and methods of their usePREVEP LLC·Filed 2020·Application pending·0 cites
- 3148US2011190245A1Nanosuspension with antifungal medication to be administered via inhalation with improved impurity profile and safetyRUNDFELDT CHRIS·Filed 2009·Application pending·0 cites
- 3247US7947705B27-azaindoles and the use thereof as therapeutic agentsBIOTIE THERAPIES GMBH·Filed 2007·Granted May 24, 2011·0 cites·6 claims
- 3347US5994347AFor a process for treatment of anxiety and tensionDRESDEN ARZNEIMITTEL·Filed 1998·Granted Nov 30, 1999·11 cites·3 claims
- 3446US2006128758A14-,6- or 7-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agentsHOFGEN NOBERT·Filed 2006·Application pending·0 cites
- 3545US2008095741A1R-(+)-alpha-liponic acid for the prevention of diabetesMEDA PHARMA GMBH & CO KG·Filed 2007·Application pending·0 cites
- 3644US2009318507A2Potassium Channel Activators for the Prevention and Treatment of Dystonia and Dystonia Like SymptomsRUNDFELDT CHRIS·Filed 2007·Application pending·0 cites
- 3743US6500821B14-amino-1-aryl-1,5-dihydropyrrol-2-ones and process for makingDRESDEN ARZNEIMITTEL·Filed 2000·Granted Dec 31, 2002·0 cites·11 claims
- 3843US2004038958A1Topical treatment of skin diseasesFiled 2003·Application pending·0 cites
- 3943US2004116501A1Treatment of nonallergic rhinitis by selective phosphodiesterase 4 inhibitorsFiled 2003·Application pending·0 cites
- 4043US2009143392A1Methods of Treating Obesity and Metabolic DisordersELBION GMBH·Filed 2008·Application pending·0 cites
- 4141US2004266760A15-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agentsFiled 2004·Application pending·0 cites
- 4234US2003186997A12,5-Dihydro-pyrazolo[3,4-d]pyrimidin-4-ones with an anticonsulsive action and methods for producing the sameFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →